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Adaptive immune system the antigen-speciﬁc line of defence, which is activated
and expanded in response to chemical and molecular signals from the innate
immune system. These signals are delivered via antigen-presenting cells (APCs).
The type of signals received and the resulting cytokine response determine the
nature of adaptive response. Adaptive immune responses are induced by
vaccination and have a memory response component
Adaptor molecules speciﬁc intracellular molecules, which modify and manipulate
signals sent by pattern recognition receptors (PRRs) to the nucleus of the cell to
inﬂuence the proﬁle of gene expression and nature of the response (eg cytokine
proﬁles)
Adjuvant (vaccine adjuvant) substance(s) included in a vaccine formulation to
enhance the quality and strength of the immune response induced by the
vaccine antigen(s)
Adjuvant System (AS) a term used to describe proprietary adjuvant combinations
Adjuvant technology application of an understanding of the properties and effects
of adjuvants in order to obtain the speciﬁc type of immune response desired
according to several criteria: disease, target population, antigen, route of
administration and persistence of immunity
Afﬁnity the strength of the interaction between a single antigen and a single
antibody, eg between an antigen and the antigen-binding site on an antibody
(see Avidity)
Afﬁnity maturation the generation of B-cell receptor variants through the
accumulation of somatic mutations and the selection of mutant B-cell receptors 2011 Elsevier B.V.
doi:10.1016/j.pervac.2011.05.009
Open access under CC BY-NC-ND license. 
XII UNDERSTANDING MODERN VACCINESexpressing the highest afﬁnity for antigen. Afﬁnity maturation occurs in secondary
lymphoid organs in specialised structures termed ‘germinal centres’ and typically
occurs following repeated exposure to the same antigen. This process is
responsible for the secretion of antibodies bearing high afﬁnity for antigen
Antibody a soluble immunoglobulin, comprised of two light chains (small
polypeptide subunits) and two heavy chains (larger polypeptide subunits), that
binds to antigen. The binding of antibodies to antigens can result in the functional
neutralisation or opsonisation of a pathogen or toxin. Binding of antibody may
cause the antigen to be recognised and ingested by phagocytes
Antigen (anti[body]-gen[erator]) a molecular structure that can be recognised by
the adaptive immune system (ie through a speciﬁc B-cell receptor or a T-cell
receptor)
Antigen-presenting cell (APC) a cell that has the capacity to express antigen/
major histocompatibility complex (MHC) at the cell surface. ‘Professional’ APCs
(such as dendritic cells [DCs], macrophages and B cells) have the ability to
internalise and degrade antigen, and then present the resulting antigenic
peptides in association with MHC class II molecules to Tcells. Dendritic cells are
the most efﬁcient APCs and the only APC capable of activating naïve T cells
Antitoxin antibodies that bind to and inactivate toxins produced by certain bacteria
Apoptosis also known as programmed cell death; a form of a highly regulated,
non-inﬂammatory cell death, characterised by a series of intracellular
biochemical steps, ultimately leading to formation of discrete sub-cellular bodies
that are removed by phagocytes. This form of cell death minimises the
extracellular release of intracellular components, thus avoiding an inﬂammatory
reaction
AS01 a proprietary adjuvant combination consisting of liposomes, MPL and QS21
AS02 a proprietary adjuvant combination consisting of oil-in-water emulsion, MPL
and QS21
AS03 a proprietary adjuvant combination consisting of oil-in water emulsions
including squalene, a-tocopherol and polysorbate 80 (Tween 80)
AS04 a proprietary adjuvant combination consisting of MPL and aluminium salts
AS15 a proprietary adjuvant combination consisting of liposomes, MPL, QS21 and
CpG 7909
Autocrine cellular self-stimulation through expression of a soluble factor
Autoimmunity a pathological, adaptive immune response directed against
self-antigen(s) (eg normal tissue components)
Avidity a measure of the overall strength of the interactions between an antigen with
multiple antigenic determinants and multivalent antibodies (see Afﬁnity)
B cell (or B lymphocyte) one of the two major types of lymphocytes that recognise
speciﬁc antigens. Upon activation, a B cell can proliferate and generate plasma
cells, producing antibodies with the same antigen-binding speciﬁcity as the
original B cell. B cells originate in the bone marrow and undergo a series of
maturation steps in the bone marrow and secondary lymphoid tissues
B-cell memory activated B cells can differentiate into memory B cells. Memory B
cells persist for long periods of time (many years in some cases) after the
immunising event and can be rapidly reactivated to differentiate into plasma
cells (antibody-producing cells). The memory response derives from a few,
GLOSSARY XIIIhigh-afﬁnity precursor B cells that have undergone signiﬁcant clonal expansion.
Their surface receptors and secreted antibodies have high afﬁnity for a speciﬁc
antigen
B-cell mitogens substances that cause B cells to proliferate
Basophils the least common of the granulocyte form of white blood cell. Basophils
play a role in the inﬂammatory response to parasitic infection and allergy, via
responses mediated by IgE antibodies binding to speciﬁc receptors expressed
at the basophil surface. When activated, basophils degranulate to release
histamine, proteoglycans (eg heparin and chondroitin), proteolytic enzymes (eg
elastase and lysophospholipase), lipid mediators (leukotrienes) and several
cytokines. These contribute to the inﬂammatory response. Basophils are of bone
marrow/haematopoietic origin
Bioinformatics the application of statistics and computer science to the ﬁeld of
biology, most often molecular biology. Bioinformatics is used to compare and
relate gene and genome sequences, identify protein function, interpret
transcription analyses and has been most powerful in those areas of genomics
involving large-scale DNA sequencing
Booster immunisation immunisation given after a primary immunisation to
enhance or sustain protection
Cachexia loss of body mass that cannot be reversed nutritionally
Cathelicidin a small-molecule peptide that acts as a stress signal within the immune
system and has direct antimicrobial properties
CD4D Tcell (or T lymphocyte) a T-cell subset that expresses CD4 (a glycoprotein
receptor and helper T-cell determinant). CD4 binds MHC class II to facilitate the
interaction between CD4þ T cells and APCs expressing MHC class II. Activated
CD4þ T cells can differentiate into T helper cells, which are deﬁned by their
pattern of cytokine expression
CD8D T cell a T-cell subset that expresses CD8 (a glycoprotein receptor and
cytotoxic T-cell determinant). CD8 binds MHC class I and facilitates the
interaction between CD8þ T cells and APCs expressing MHC class I. Activated
CD8þ T cells can differentiate into antigen-speciﬁc CD8þ cytotoxic T cells
Chemokine a soluble protein acting as a chemotactic factor. Chemokines regulate
cell migration and attract cells into particular locations such as lymphoid organs
or infected sites
Clonal deletion the iterative process by which lymphocytes expressing self-reactive
receptors are instructed to die by apoptosis (thus avoiding autoimmunity)
Clonal selection (theory) a central concept of adaptive immunity. Cells expressing
receptors speciﬁc for foreign antigens are induced to divide in a clonal fashion,
giving rise to a set of cells expressing similar antigen-speciﬁc receptors. The
ability to selectively expand cells expressing particular antigen-speciﬁc receptors
represents the cellular basis of adaptive immunity
Clone a population of cells expressing the same surface receptor speciﬁcity, derived
from a single progenitor cell
Cold attenuation the process of altering a virus so that it cannot replicate above
a certain temperature (usually below human core body temperature)
Complement receptor a cell surface protein that recognises and binds activated
complement proteins (see also Complement system). Complement receptors on
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destroyed by phagocytes
Complement system part of the innate immune system, the complement system
consists of blood plasma proteins. These proteins can be activated in a cascade
by binding directly to a pathogen or by binding to antibodies engaged with
a pathogen. Complement activation can kill pathogens directly or indirectly by
promoting phagocytosis of the pathogen
Complement cascade the stepwise activation of complement components
Conjugation the joining of two molecules or substances by a strong chemical bond
Conjugate vaccine a vaccine where an antigen is linked to a carrier protein using
a chemical process to enhance the immune response to the antigen. Conjugate
vaccines are typically used in vaccines against pathogenic bacteria when the
target antigen is not a protein or peptide, but a polysaccharide
Correlates of immunity/protection ‘measurable’ signs, usually quantitative
laboratory assays of T cells or antibodies, that indicate a person has had an
immune response sufﬁcient to protect against infection caused by a speciﬁc
pathogen (eg the presence of a critical titre of antibodies)
Cortical follicles (see Lymphoid follicles)
Co-stimulatory signal signal required in conjunction with antigen-binding for
lymphocyte proliferation
Cytokine soluble proteins released by cells that affect the behaviour of other
cells. Cytokines made by lymphocytes are often called lymphokines or
interleukins (IL). Cytokines also include the tumour necrosis factor (TNF) and
interferon families
Cytotoxic T cell (cytotoxic T lymphocyte; CTL) mostly effector CD8þ T cells that
can target and kill cells displaying antigen at their surface, such as virus-infected
cells. These antigens are recognised by cytotoxic T-cell receptors
Danger-associated molecular patterns (DAMPs) normal cell constituents (such
as adenosine triphosphate [ATP], or uric acid) often released by stressed or
dying cells as a consequence of infection or trauma. DAMPs are recognised by
and activate cells of the innate immune system
Defensins small-molecule peptides that act as stress signals within the immune
system and also have direct antimicrobial properties
Dendritic cell (DC) a type of cell of the innate immune system that is present in most
tissues of the body and considered to be the most efﬁcient APC type. Upon
activation and uptake of antigen, peripheral DCs are stimulated to migrate to
lymphoid organs where they drive de novo immune responses
Disease burden the impact of a health problem in a region or population measured
by healthcare cost, mortality, morbidity, social disruption or other indicators
DNA/RNA sensors molecular recognition systems that detect non-eukaryotic DNA
or double-stranded RNA
Effector T cell differentiated T cell that has cytotoxic or helper functions in the
immune response. These cells are characterised by the ability to secrete high
levels of soluble effector molecules (including cytotoxic components and
inﬂammatory cytokines) affecting pathogen survival. Effector T cells generally
display enhanced antigen recognition and often localise in inﬂamed and infected
tissues
GLOSSARY XVEndocrine stimulation of distant cells via the secretion of soluble factors
(see Autocrine)
Endocytosis the process of particle internalisation into a cell that begins with the cell
membrane, extending to surround the particle, and ends with an invaginated
membrane compartment that is pinched off inside the cell to form an intracellular
vesicle
Endotoxin lipopolysaccharide (LPS), an endotoxin, forms part of the outer envelope
of Gram-negative bacteria. Endotoxin induces fever in low doses and is very toxic
in high doses. It is released from the bacteria during growth and death from, for
example, antibiotic-mediated lysis
Eosinophil a granulocyte form of white blood cell more abundant than basophils.
Upon activation, eosinophils can migrate to sites of parasitic infection. They can
function as a phagocyte and release the cytotoxic contents of their intracellular
granules into the extracellular environment. Eosinophils are of bone marrow/
haematopoietic origin
Epitope the highly speciﬁc structure or site on an antigen that is recognised by either
the surface B-cell receptor, T-cell receptor or soluble antibody. The same
sequence can act as both a B-cell epitope and a T-cell epitope, but more often
the major B-cell epitopes are not T-cell epitopes
Exotoxin a protein toxin actively secreted by bacteria into the surrounding
environment, eg tetanus toxin, diphtheria toxin, pertussis toxin
Follicular dendritic cells antigen-presenting cells (APCs) residing within secondary
lymphoid tissues with long-branching processes that make intimate contact with
many different B cells, and are crucial in selecting antigen-binding B cells during
antibody responses
Follicular helper cells (Tfh cells) a subset of effector (‘helper’) CD4þ T cells,
characterised by their secretion of IL-21. Tfh cells function by promoting antibody
production by B cells. See Helper (h) T cell and Effector T cells
Germinal centres during antibody responses, these are sites of B-cell proliferation,
selection, maturation and death in secondary lymphoid tissues
Helper (h) Tcell There are at least four classes of Th cells that are characterised in
terms of the predominant cytokines they secrete. Th1 cells secrete mainly IFNg;
Th2 cells, IL-4, IL-5 and IL-13; Th17, IL-17 and IL-22; and Tfh cells, IL-21. Three
classes, Th1, Th2 and Tfh also differ in the effects they have on antibody
production by B cells. Th1 cells can also directly activate macrophages that
display the antigen recognised by their T-cell receptor to enhance their
microbicidal activity. Th17 cells are typically involved in organ-speciﬁc responses
such as in the lung and gut
Homeostatic responses aimed at maintaining physiological normality
Human leukocyte antigen (HLA) see Major histocompatibility complex (MHC)
Humoral immunity antibody-mediated speciﬁc immunity e a key part of the
adaptive immune response
Immune memory the retention of a pool of cells speciﬁc for a particular infectious
agent, providing a mechanism to speciﬁcally prevent subsequent disease
caused by the same agent
Immune paralysis the inhibition of immune responses caused by interactions with
previous or concurrent immune responses
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an adaptive immune response
Immunogen an antigen capable of inducing an adaptive immune response
Immunogenic possessing the ability to elicit an immune response
Immunogenicity the property of being able to elicit an immune response
Immunoglobulin (Ig) a protein complex made up of four polypeptide subunits two
polypeptide subunits with a molecular weight of approximately 25,000 daltons
each (light chains), and two polypeptide subunits with a molecular weight of
approximately 50,000 daltons each (heavy chains). Immunoglobulins include
antibodies and plasma membrane-bound antigen receptors on the surface
of B cells
Immunological/antigenic interference the modulation of an immune response to
a given antigen due to concurrent or previous exposure to other antigens (see
Immune paralysis)
Immunological (immuno) senescence a physiological state that occurs with
increasing age and leads to a decline of innate and adaptive immune responses
in the elderly
Inactivated vaccine a vaccine made from a pathogen that has been killed by
a physical or chemical process. It stimulates speciﬁc immunity against the
pathogen, but cannot cause disease. Also known as a killed vaccine
Innate immune system part of the immune system that elicits protective immune
responses against a pathogen by recognition of common molecular
determinant(s) shared by many pathogens (see Pathogen-associated molecular
patterns [PAMPs]) or that arise from tissue damage. The innate immune system
acts rapidly and has no capacity for immune memory. See Complement system
Innate T cells T cells which are not dependent on the activity of APCs to become
activated. Innate T cells may directly recognise antigen or become activated by
proinﬂammatory cytokines and molecular signals
Inoculate to introduce an infectious disease into a host in order to induce immunity
against the same disease (see Variolation)
Integument system the physical and chemical barriers that comprise the body’s
ﬁrst line of defence; includes the skin, ciliated epithelia, mucous membranes,
stomach acids and protective enzymes in secretions
Interferon (IFN) cytokine that can induce cells to resist viral replication
Interleukin (IL) cytokine produced by leukocytes
Intussusception enfolding of one segment of the intestine within another
ISCOM/ISCOMATRIX complex formulation of lipids and adjuvant components
in which the antigen is embedded within a cage-like structure (ISCOM), or
where the lipid and adjuvant mixture is added to antigen (ISCOMATRIX)
Isotype switching isotypes refer to the distinct classes of antibody that occur (IgM,
IgG, IgD, IgA, IgE). Antibodies initially secreted are of the IgM isotype. Activated
B cells undergo isotype switching to secrete antibodies of other classes, with
discrete effector mechanisms, when they are bound via the Fc-domains of
antibodies to a particular antigen
Latency refers to the persistence of a pathogen within a cell in a dormant,
non-replicative state. Latency implies maintenance of genetic material of
pathogenic origin in a cell, with no replication or cell-surface expression of
GLOSSARY XVIIpathogenic proteins. As a consequence, latent pathogen may not be detected
by the immune system but can reactivate and cause recurrent infections
Lipopolysaccharide (LPS) an endotoxin that is a natural component of the
outer membrane of Gram-negative bacteria and an agonist of TLR4 (see
Monophosphoryl lipid A [MPL])
Liposome artiﬁcial vesicles comprising an aqueous core enclosed in one or more
lipid layers, which have been developed and studied for more than 30 years as
a way to deliver drugs to cells. Liposomes alone are usually inert carriers and
hence are not immunogenic. Over the last 20 years, this technology has been
applied to vaccines in order to deliver antigens and adjuvants to APCs
Live, attenuated vaccine a vaccine which uses live but much less virulent
organisms to induce immunity. May be based on a live virus that is a less virulent
form of the pathogenic strain targeted by the vaccine
Live vector vaccine a vaccine where the targeted antigenic constituent is expressed
by a second, usually unrelated, live virus or bacterium that is not pathogenic. The
antigen is encoded by a gene or gene(s) that is/are incorporated into the carrier
virus or bacterium’s genetic material
Lymphoid follicles cortical areas of the lymph nodes, where B cells from the bone
marrow receive survival signals from resident follicular DCs and then replicate
forming a germinal centre
Lysozyme a peptide with enzymatic activity which acts as a stress signal to the
immune system and also has direct antimicrobial properties
MF59microﬂuidised oil-in-water emulsion adjuvant that consists of the surfactants
Span 85, Tween 80 and the oil squalene. MF59 appears to promote
antigen uptake by APCs, and enhances antibody production and T-cell
proliferative responses
Macrophage tissue-resident cell family derived from a bone marrow precursor,
deﬁned by its relatively large size and phagocytic activity. Macrophages can also
function as APCs and as a source of cytokines
Major histocompatibility complex (MHC) also known as HLA complex in humans.
A multiple-gene family, the MHC encodes proteins that form subunits of
membrane-spanning antigen-presenting molecules. The MHCmolecules bind to
protein antigens inside the cell, prior to delivery of the MHC/antigen complex to
the cell surface. Two classes of MHC molecules (MHC class I and II) are deﬁned
by different subunit proteins and differences in the source of the antigens they
bind; MHC class I typically binds antigens derived from the processing of
endogenous proteins, including foreign molecules such as viral proteins. MHC
class II typically binds antigens derived from the external environment, including
proteins internalised by endocytosis or phagocytosis
Marginal zone the area between white pulp (mostly composed of Tand B cells) and
the red pulp (containing non-lymphoid cells) of the spleen. The marginal zone
acts as a ﬁlter, trapping antigen from the blood and presenting them to
lymphocytes to initiate an immune response
Mast cell a tissue-resident granular phagocyte found in several tissues of the body,
including the skin and mucosa. Upon activation by binding IgE or complement,
a mast cell can release the contents of its intracellular granules, rich in histamine
and heparin, into the extracellular space. These molecules contribute to
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and inhibiting coagulation
Memory response an enhanced and rapid adaptive immune response raised on
secondary exposure to a previously encountered antigen
Microbe microscopic organisms including bacteria, viruses, fungi and protozoa
Microbiome the microorganisms that constitute the ﬂora characteristic of a
particular environment within a host (usually excludes viruses)
Monocyte a blood-resident leukocyte of bone marrow/haematopoietic origin that
migrates on activation to sites of tissue damage and infection, and can function
as a phagocyte. Monocytes are a precursor of some classes of DCs and can
also differentiate into types of macrophages
Monophosphoryl lipid A (MPL) a puriﬁed derivative of LPS from the Salmonella
minnesota R595 cell wall. MPL has adjuvant properties due to its ability to directly
activate key innate immune mechanisms, including the activation of APCs, which
in turn enhance the adaptive immune response. It has been established that
this activation is achieved through Toll-like receptor 4, an innate receptor present
on APCs
Montanide ISA51 a stabilised water-in-oil emulsion adjuvant combined with
a speciﬁc antigen to enhance the immune response to that antigen
Multivalent having more than one molecular binding site or speciﬁcity
Naïve lymphocyte (B or T cell) lymphocyte that has not encountered its speciﬁc
antigen and therefore has not been activated to become an effector or memory
lymphocyte
Natural immunity adaptive immune responses (serological and cellular) that result
from the successful control of an infection and provide protection against
subsequent reinfection or disease; compared to vaccine immunity: adaptive
immune responses (serological and cellular) induced by vaccination that
provide protection against subsequent pathogen-speciﬁc infection and limit its
consequence for disease
Natural killer (NK) cell a cytotoxic leukocyte that can identify and be activated by
pathogen-infected cells or tumour cells, which can directly or indirectly cause
their death. Natural killer cells originate in the bone marrow, are part of the innate
immune system and can be activated by low or absent cell surface expression of
molecules such as MHC class I
Negative selection the process by which maturing T cells in the thymus,
that recognise antigens derived from self-proteins, are deleted from the
repertoire
Neutrophil the largest constituent of the granulocyte form of white blood cell.
Neutrophils can migrate to sites of tissue damage and infection, and function as
phagocytes. Neutrophils are of bone marrow/haematopoietic origin
Open reading frames (generally referred to as ‘genes’) the regions of a genome
deﬁned by the presence in DNA of start and stop codons in the same reading
frame, which can potentially encode proteins
Opsonisation the process by which the binding of antibodies or complement
to the surface of a pathogen renders the pathogen more susceptible
to phagocytosis
GLOSSARY XIXPandemic a disease outbreak occurring over a very large area, usually more than
one continent. According to the World Health Organization, a pandemic is ‘the
worldwide spread of an infectious disease’
Paracrine stimulation of neighbouring cells, via the secretion of soluble factors
(see Autocrine, Endocrine)
Parasite organisms that obtain sustenance from a live host, a term most commonly
applied to worms and protozoa
Particulate antigens insoluble antigens, which tend to be more immunogenic than
soluble antigens
Pathogenicity (also called virulence) the relative ability of a pathogen to cause
pathology in an infected host
Pathogen-associated molecular patterns (PAMPs) conserved molecular
structures that are distinctive for a class of pathogen and are recognised by
innate immune receptors
Pattern recognition receptors (PRRs) innate immune receptors (eg Toll-like
receptors) that recognise a series of common molecular structures (eg
PAMPs) expressed by pathogens
Peripheral blood mononuclear cells lymphocytes and monocytes isolated from
peripheral blood
Peripheral lymphoid organs the lymph nodes, spleen and mucosal-associated
lymphoid tissues, in which immune responses are induced. Also referred to as
secondary lymphoid organs
Phagocyte a cell of the immune system, such as a DC, monocyte, macrophage, mast
cell or neutrophil, that phagocytoses (ingulfs/internalises) extracellular (insoluble)
material to create an intracellular vesicle (phagosome). The phagosome fuses with
lysosomes resulting in the degradation of the phagocytosed material, including
destruction of engulfed or intracellular infectious agents
Phagocytosis a type of endocytosis involving the vesicular internalisation of
particulate material, such as bacteria, by a phagocyte
Pharmacokinetics the study of how the body handles drug substances, including
the processes of absorption, distribution, metabolism and elimination
Pharmacovigilance the processes involved in long-term safety monitoring of drugs
and pharmaceutical products
Phosphokinase key enzymes in signal transduction
Plasma protein proteins carried in the plasma
Plasma cell antibody-secreting form of a B cell
Plasmid a circular piece of DNA into which individual genes can be inserted
Plasmid vector see Plasmid
Positive selection the process by which only developing T cells that recognise
MHC are induced to mature in the thymus
Primary immune response the adaptive immune response to initial exposure
to antigen (see also Adaptive immune system). Primary immunisation, also
known as priming, generates both the primary immune response and the
development of immunological memory. Primed cells can either differentiate into
effector cells or into memory cells that can respond in second and subsequent
immune responses
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transcription of an adjacent gene, through the binding of the RNA polymerase
complex
Prophylactic vaccine a vaccine preventing infection or disease in subjects not
previously exposed to the target pathogen
Quality-adjusted life-year (QALY) a measure used to evaluate the relative costs
and beneﬁts of a healthcare intervention
QS21 a triterpene glycoside with adjuvant properties derived from a saponin
extracted from the bark of the South American Quillaja saponaria tree
RC-529 an aminoalkyl gluocosaminide-4-phosphate (AGP) compound that activates
immune cells, including macrophages, B cells and DCs. RC-529 signals through
TLR4, and induces the up-regulation of cell-surface co-stimulatory molecules and
receptors, cytokines and chemokines
Reactogenicity the extent of the adverse reactions solicited and reported after
vaccination. This is typically measured in humans in terms of acute pain, redness
and swelling local to the injection site; and systemically in terms of acute muscle
pain, headaches, fatigue and fever
Reassortant a virus in which segments of its genome are derived from different
strains of the same organism
Reassortment the process of generating a reassortant
Recombinant DNA/recombinant protein vaccine a vaccine made by
manipulating pathogen-derived genes to yield a recombinant protein containing
the target antigen, typically expressed in yeast, baculovirus or Escherichia coli
(see Subunit antigen)
Regulatory T cells (Treg cells) T cells that suppress the activation of the immune
system through various mechanisms, maintaining immune homeostasis and
tolerance to self-antigens. Regulatory (hence, reg) T cells are characterised by
the expression of CD4, the IL-2 receptor CD25, and the transcription factor
FOXP3
Reverse vaccinology the selection of antigens for a vaccine using a combination of
genetics, bioinformatics and laboratory testing. Candidate peptide or protein
(recombinant DNA protein) antigen sequences are selected from a bioinformatic
screen of the pathogen’s genome. Further selection of the most promising
candidates is then undertaken in the laboratory and through testing experimental
models
Secondary lymphoid organs (see Peripheral lymphoid organs)
Secondary immune response the immune response induced by a second or
booster injection of antigen. Due to immune memory, these responses develop
rapidly compared with primary responses and display increased intensity and
afﬁnity (such as higher levels of high-afﬁnity circulating antibodies)
Self-antigen antigens derived from self-tissues
Self-tolerance failure to initiate an immune response to a self-antigen
Seronegative lacking antibody to a speciﬁc antigen
Seroprotection the induction of antibody of a protective serum concentration or titre
Serous thin and watery ﬂuid, like serum
Somatic cells non-reproductive cells of the body
GLOSSARY XXISubunit antigen (also known as a ‘subcellular/subvirion vaccine’) an antigen
prepared by chemical treatment and/or physical separation from other
pathogen constituents, or produced using recombinant DNA technology (see
Recombinant protein vaccine)
Surfactant an amphiphilic substance composed of lipoprotein that reduces the
surface tension of ﬂuids. Surfactants have physicochemical properties of
self-aggregation, solubilisation or emulsiﬁcation. For the purpose of vaccines,
they can be used as adjuvants, solubilisers or stabilisers of emulsions
T cell (T lymphocyte) leukocytes that originate in the bone marrow and mature in
the thymus, before trafﬁcking to the secondary lymphoid organs (see CD4þ
T cell, CD8þ T cell, Cytotoxic T cell, Helper [h] T cell)
T-cell determinant the portion of an antigen that is recognised by the T-cell receptor
T-cell independent (TI) antigens antigens that can elicit antibody production
without the ‘help’ provided by T cells
T-cell independent antigens (Type I) T-cell independent antigen that has intrinsic
polyclonal B-cell activating activity
T-cell independent antigens (Type II) T-cell independent antigen that has intrinsic
capacity to activate antigen-speciﬁc B cells following speciﬁc interaction with the
B-cell receptor (BCR). These generally display repetitive antigenic structures,
enabling them to interact simultaneously with multiple BCRs expressed by
a single B cell
T-cell zone the region of the lymph node where T cells reside and are activated by
trafﬁcking APCs
T-cell dependent antigen an antigen that requires the stimulation of Tcells to induce
an optimal immune response, such as high levels of circulating antibodies
T helper type 1 cells (Th1) a subset of effector (‘helper’) CD4þ Tcells, characterised
by their secretion of IFNg. Th1 cells function mainly by activating macrophages
(see Helper [h] T cell and Effector T cell)
T helper type 2 cells (Th2) a subset of effector (‘helper’) CD4þ Tcells, characterised
by their secretion of IL-4, IL-5 and IL-13. The main functions of Th2 cells are in the
activation of anti-parasite responses and allergic-type responses, via secretion of
cytokines that activate granulocytes (see Helper [h] T cell and Effector T cell)
Teratogenicity the ability to cause damage to the developing foetus or to the
germline cells (sperm, ovum)
Therapeutic vaccine a vaccine designed to treat an existing infection (eg chronic
hepatitis B virus, tuberculosis) or disease (eg prostate cancer)
Thymus a lymphoepithelial organ located behind the sternum that is the site of T-cell
development
Titre the reciprocal of the highest dilution of antibody necessary to yield a positive
result in a test, eg enzyme-linked immunosorbent assay (ELISA)
Tolerance failure to respond to an antigen. Tolerance is generally maintained against
self-antigens (see Self-tolerance) and innocuous non-self-antigens present in the
environment (such as air-borne particles, food components). This can occur by
several mechanisms, but principally by deletion of immature T cells bearing
receptors that recognise such antigens, or by the activation of populations of
regulatory T cells that inhibit responses to those antigens
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molecular patterns (see Pattern recognition receptors [PRRs]) common to many
pathogens, resulting in activation of the innate immune response
Toxoid an inactivated form of a toxin, often used as a vaccine against the toxin.
A toxoid is derived from a toxin by inactivating (chemically) the toxic property
without altering the antigenic qualities that induce antibodies
Transcription factor a protein that binds to a promoter sequence, thereby
controlling the transfer (or transcription) of genetic information from DNA
to mRNA
Vaccination the administration of a vaccine to induce immunity against a speciﬁc
pathogen
Vaccinology the science and methodology of vaccine development
Viral neutralisation the binding of an antibody to a virion, preventing virus entry to
host cells
Variolation speciﬁcally refers to the method of intentionally inoculating a person
intradermally with a mild strain of smallpox to induce immunity against naturally
acquired virulent smallpox. This early method of combating smallpox epidemics
was superseded by the use of the vaccinia (cowpox) virus for vaccination against
smallpox (see Vaccination, Inoculate)
Virosome liposomes that carry viral glycoproteins on their surface, mimicking
a viral structure. Virosomes do not contain genetic material and hence are
non-infectious and unable to replicate. In vaccines, virosomes can be used as
carriers of vaccine antigens and lipophilic adjuvants. They also have intrinsic
adjuvant activity because the body recognises the viral glycoproteins as
a microbial antigen
Virulence the relative ability of any infectious agent to produce disease (see
Pathogenicity)
Virulence determinants/factors the features of an organism that make it
pathogenic and typically make good vaccine targets
